Results 1 to 10 of about 75,936 (164)

Impact of a Hybrid Prevention Program for High School Students on Prescription Drug Misuse Outcomes [PDF]

Behavioral Sciences
Prescription drug misuse among youth is a significant public health problem that can lead to negative consequences, including addiction and overdose deaths.
Kenneth W. Griffin, Christopher Williams, Sandra M. Sousa, Gilbert J. Botvin   +3 more
doaj   +2 more sources

Effort–Reward Imbalance at Work and Drug Misuse: Evidence from a National Survey in the U.S. [PDF]

International Journal of Environmental Research and Public Health, 2021
Jian Li, Timothy A Matthews, Liwei Chen   +2 more
exaly   +2 more sources

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

Brain Sciences, 2023
The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes.
Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi, Fabrizio Schifano   +7 more
doaj   +1 more source

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach

Frontiers in Psychiatry, 2021
COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of
Valeria Catalani, Davide Arillotta, John Martin Corkery, Amira Guirguis, Amira Guirguis, Alessandro Vento, Alessandro Vento, Alessandro Vento, Fabrizio Schifano   +8 more
doaj   +1 more source

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis

Brain Sciences, 2021
The restrictive measures adopted during the COVID-19 pandemic modified some previously consolidated drug use patterns. A focus on social networks allowed drug users to discuss, share opinions and provide advice during a worldwide emergency context.
Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum, Fabrizio Schifano   +4 more
doaj   +1 more source

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity

Pharmaceuticals, 2021
Designer benzodiazepines (DBZDs) represent a serious health concern and are increasingly reported in polydrug consumption-related fatalities. When new DBZDs are identified, very limited information is available on their pharmacodynamics.
Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum, Fabrizio Schifano   +6 more
doaj   +1 more source

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases

Pharmaceuticals, 2022
Despite increasing reports, antidepressant (AD) misuse and dependence remain underestimated issues, possibly due to limited epidemiological and pharmacovigilance evidence.
Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano   +5 more
doaj   +1 more source

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

Brain Sciences, 2018
Recently, a range of prescription and over-the-counter drugs have been reportedly used as Novel Psychoactive Substances (NPS), due to their potential for abuse resulting from their high dosage/idiosyncratic methods of self-administration.
Fabrizio Schifano, Stefania Chiappini, John M. Corkery, Amira Guirguis   +3 more
doaj   +1 more source

What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs

Brain Sciences, 2020
Recently, a range of prescription and over-the-counter (OTC) drugs have emerged as being used recreationally, either on their own or in combination with other substances, both licit and illicit, including new psychoactive substances (NPS).
Stefania Chiappini, Fabrizio Schifano
doaj   +1 more source

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)

Pharmaceuticals, 2022
In the past twenty years, the consumption of opioid medications has reached significant proportions, leading to a rise in drug misuse and abuse and increased opioid dependence and related fatalities.
Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Daniel R. Harris, Fabrizio Schifano   +6 more
doaj   +1 more source